Door to balloon and door to needle: Temporal trends in delays to reperfusion

Israel Medical Association Journal

Volumn 5, Issue 12, 2003, Pages 852-855

  Wolak, Arik ^a,b   Gilutz, Harel ^a,b   Amit, Guy ^a,b   Cafri, Carlos ^a,b   Ilia, Reuben ^a,b   Zahger, Doron ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Myocardial infarction; Primary percutaneous coronary intervention; ST elevation; Thrombolysis; Time delay

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CORONARY CARE UNIT; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NEEDLE; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; TIME; TIME MANAGEMENT;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0348149206     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zijlstra F, Hoorntje JC, De Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341(19):1413-19.
2. Grines CL, Westerhausen DR Jr., Grines LL, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 2002;39(11):1713-19.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
4. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 2003;24(1):94-104.
5. Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 2003;145(1):47-57.
6. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999;34(3):890-911.
7. Van De Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24(1):28-66.
8. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283(22):2941-7.
9. Berger PB, Bell MR, Holmes DR Jr, Gersh BJ, Hopfenspirger M, Gibbons R. Time to reperfusion with direct coronary angioplasty and thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1994;73(4):231-6.
10. Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998;31(6):1240-5.
11. Behar S, Battler A, Porath A, et al. for the Israel Heart and Internal Medicine Societies. A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000. IMAJ 2003;5:249-54.
12. The Working Group on Intenstive Cardiac Care of the Israel Heart Society. Israel Center for Disease Control PN, April 2003. (The Israel Society for the Prevention of Heart Attacks, the Israel Center for Disease Control of the Ministry of Health.). ACSIS 2002 (Acute Coronary Syndromes - Israel 2002), National Survey, February-March 2002, Preliminary Findings. 2003 April 2003. Report No. 230.
13. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343(6):385-91.
14. Loubeyre C, Morice MC, Lefevre T, Piechaud JF, Louvard Y, Dumas P. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol 2002;39(1):15-21.
15. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344(25):1895-903.
16. Goldman L. Cost and quality of life: Thrombolysis and primary angioplasty. J Am Coll Cardiol 1995;25(7 Suppl):38-41S.
17. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002;23(15):1190-201.
18. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90(4):358-63.
19. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial. Assessment of the safety and efficacy of new thrombolytic investigators. Lancet 1999;354:716-22.
20. Every N WW, Parsons L, Martin JS, Direct PTCA vs thrombolysis: Immediate and one year outcome and procedure utilization for the two treatment strategies [Abstract]. Circulation 1995;92(Suppl 1):1-138.
21. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328(10):673-9.
22. De Boer MJ, Hoorntje JC, Ottervanger JP, Reiffers S, Suryapranata H, Zijlstra F. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: Left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994;23(5):1004-8.
23. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med 1993;328(10):685-91.
24. Gilutz H, Battler A, Rabinowitz I, Snir Y, Porath A, Rabinowitz G. The "door-to-needle blitz" in acute myocardial infarction: The impact of a CQI project. J Comm J Qual Improv 1998;24(6):323-33.
25. Weaver WD. Time to thrombolytic treatment: Factors affecting delay and their influence on outcome. J Am Coll Cardiol 1995;25(7 Suppl):3-9S.